Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors
Sponsor: Memorial Sloan Kettering Cancer Center
Summary
This study will test whether minoxidil taken by mouth (oral minoxidil) can improve hair loss caused by cancer treatment in children and young adults. In addition, the researchers will test the safety of oral minoxidil, and see if the study drug causes few or mild side effects in participants. Other purposes of this study include looking at whether participants are able to follow their study drug dosing schedules, and how oral minoxidil affects participants' quality of life.
Official title: A Pilot Study of Oral Minoxidil for the Treatment of Persistent Hair Loss in Pediatric, Adolescent, and Young Adult Cancer Survivors
Key Details
Gender
All
Age Range
6 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2023-03-10
Completion Date
2027-03
Last Updated
2026-02-20
Healthy Volunteers
No
Conditions
Interventions
Oral Minoxidil
minoxidil at a dose of 0.01 (\<40kg) and 0.02 (≥40kg) mg/kg/day
Placebo
placebo for 4 months
Locations (1)
Memorial Sloan Kettering Cancer Center
New York, New York, United States